e-learning
resources
Munich 2006
Monday 04.09.2006
COPD comorbidity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The relationship between depression, medication and stage of the disease in patients with COPD
I. G. Stoica (Bucharest, Romania)
Source:
Annual Congress 2006 - COPD comorbidity
Session:
COPD comorbidity
Session type:
Oral Presentation
Number:
3079
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. G. Stoica (Bucharest, Romania). The relationship between depression, medication and stage of the disease in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 3079
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR)
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Assessing the multivariate structure and influence of comorbidity in COPD
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006
The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Chronic obstructive pulmonary disease (COPD), comorbid disease, and follow-up hospitalizations in a US cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
COPD and CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Source: Eur Respir J 2013; 41: 815-823
Year: 2013
Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Some gender features of the chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept